Clinical Trials

27 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT07469306 2026-03-13

Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer

130 enrolled

Locally Advanced Rectal Cancer

NCT07416253 2026-02-18

Trastuzumab Rezetecan vs Trastuzumab Deruxtecan in the Neoadjuvant Treatment of HER2 Positive Breast Cancer

68 enrolled

Breast Neoplasms

NCT07363512 2026-01-23

Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor Thrombus

27 enrolled

Carcinoma, Hepatocellular

NCT07333287 2026-01-12

A Multicenter Single-arm Prospective Clinical Study on First-line Treatment of Pancreatic Cancer Liver Metastases With Arterial Infusion Chemotherapy and Embolization Combined With Dual Immune Checkpoint Inhibitors.

38 enrolled

Pancreatic Cancer Liver Metastases

NCT07331428 2026-01-09

MRG003 Induction and Capecitabine Maintenance With PD-1 in Locally Recurrent NPC

25 enrolled

Nasopharyngeal Carcinoma

NCT07313202 2025-12-31

Ivarmacitinib in Advanced Solid Tumors: A Prospective, Two-Cohort, Two-Phase Exploratory Study in Patients Discontinued Due to Immune Intolerance

72 enrolled

Other solid neoplasm

Patients With Advanced Solid Tumors Who Discontinued Treatment Due to irAE

NCT07256964 2025-12-02

Toripalimab Combined With Anthracycline-free or Anthracycline-containing Chemotherapy as Neoadjuvant Chemotherapy for Early Triple Negative Breast Cancer

216 enrolled

Triple Negative Breast Neoplasms

NCT07252375 2025-11-26

A Clinical Study of Hetrombopag for Prevention of Thrombocytopenia Induced by Gemcitabine Plus Cisplatin in the Treatment of Nasopharyngeal Carcinoma

35 enrolled

Nasopharyngeal Carcinoma

NCT07243418 2025-11-21

Hetrombopag for the Prevention of ADC-Induced Thrombocytopenia in Breast Cancer: An Exploratory, Dual-Cohort, Phase 2 Study

72 enrolled

Breast Neoplasms

NCT07191249 2025-09-24

A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).

30 enrolled

Lymphoid

Lymphoma, Follicular

NCT07136974 2025-08-22

Efficacy of TQB2102 Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer.

280 enrolled

Breast Neoplasms

NCT07128251 2025-08-17

A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)

47 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Carcinoma, Hepatocellular

NCT07125950 2025-08-15

SHR2554 Combined With Endocrine Therapy in Advanced Breast Cancer

Advanced Breast Cancer

NCT07108816 2025-08-07

A Single-center, Phase II Clinical Trial Evaluating the Efficacy of Sacituzumab Tirumotecan in Combination With Tagitanlimab as Neoadjuvant Therapy for PD-L1-positive, Resectable Stage II to IIIB Non-small Cell Lung Cancer (NSCLC)

52 enrolled

Resectable Stage II-IIIB NSCLC

NCT07101159 2025-08-03

Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients

200 enrolled

Breast Neoplasms

NCT07046221 2025-07-20

Tislelizumab Combined With Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma Followed by CRT or Surgery

Esophageal Neoplasms

NCT07070713 2025-07-17

Efficacy and Safety of FOLFOX+Cetuximab vs. FOLFOXIRI+Bevacizumab Both With QL1706 in First-Line Treatment of Left-Sided mCRC

44 enrolled

Metastatic Colorectal Cancer With Left-sided Primary Tumor

NCT07069270 2025-07-16

A Study on the First-line Treatment of Small Cell Lung Cancer With Adebrelimab and Vunakizumab and Chemotherapy

28 enrolled

Small Cell Lung Carcinoma

NCT07047755 2025-07-02

Trastuzumab Rezetecan Plus Pertuzumab in the Neoadjuvant Treatment of HER2 Positive BC

48 enrolled

Breast Neoplasms

NCT06819319 2025-06-23

SHR-A2102 Combined With Adebrelimab as Neoadjuvant Therapy for Early Triple-Negative Breast Cancer

52 enrolled

Triple Negative Breast Neoplasms

NCT06971406 2025-05-14

FLAME-1

100 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT06809777 2025-05-13

Comparison Between Efficacy of Topical 25%Podophyllin and Cryotherapy on Genital Warts

96 enrolled

Condylomata Acuminata

NCT06942663 2025-04-24

JAGC1

228 enrolled

Stomach Neoplasms

NCT06898983 2025-03-28

Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced Thrombocytopenia (CTIT) in the Treatment of Leukemia

97 enrolled

Classical hematology

Cancer Treatment-induced Thrombocytopenia (CTIT)

NCT06692270 2025-02-28

Tislelizumab as Single-Agent Neoadjuvant Immunotherapy in Resectable Esophageal Squamous Cell Carcinoma

20 enrolled

Esophageal Neoplasms

NCT06793228 2025-01-27

Nanocrystalline Megestrol + Immunochemo As 1st-Line for ES-SCLC Cachexia

250 enrolled

SCLC, Extensive Stage

NCT06788171 2025-01-23

PULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM

35 enrolled

Colorectal Cancer Liver Metastasis

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

34 enrolled

Small Cell Lung Carcinoma

NCT06746545 2024-12-24

A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatment of Metastatic Colorectal Cancer.

30 enrolled

Colorectal Neoplasms

NCT06654947 2024-12-16

A Single-arm, Open-label, Prospective Clinical Study of Surufatinib Combined With Immunotherapy and Chemotherapy for Unresectable or Metastatic Biliary Tract Cancer.

23 enrolled

Biliary Tract Neoplasms

NCT06685354 2024-11-12

Sequential T and I With H101 Via HAI for BCLC C Stage HCC: A Prospective Single-Center Single-Arm Pilot Study

11 enrolled

Carcinoma, Hepatocellular

NCT06670300 2024-11-01

Clinical Observation on the Safety and Efficacy of Cardonilmab in the Treatment of Second-line and Above Advanced Melanoma and Advanced Renal Cancer

DermatologicGenitourinary

20 enrolled

Kidney Neoplasms, Melanoma

NCT06663748 2024-10-29

ARX788 in HER2-positive Metastatic Breast Cancer Patients

44 enrolled

Breast Neoplasms

NCT06618391 2024-10-01

Local Injection and Systemic Therapy in the Treatment of NSCLC.

84 enrolled

Carcinoma, Non-Small-Cell Lung

NCT06614621 2024-09-26

A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer

43 enrolled

Small Cell Lung Carcinoma

NCT06600841 2024-09-19

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

37 enrolled

Gynecologic

Platinum-resistant Ovarian Cancer (PROC)

NCT06554028 2024-08-14

Tislelizumab and Induction Chemotherapy for Larynx Preservation in Resectable Advanced Laryngeal/Hypopharyngeal Cancer

46 enrolled

Hypopharyngeal Neoplasms, Laryngeal Neoplasms

NCT05628610 2024-08-13

Tislelizumab Combined With Chemotherapy or Radiotherapy in the Treatment of Advanced or Recurrent Metastatic Elderly Esophageal Cancer

130 enrolled

Esophageal Neoplasms

NCT06538935 2024-08-06

SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular Carcinoma

80 enrolled

Carcinoma, Hepatocellular

NCT06490913 2024-07-08

Chemotherapy Plus EGFR Monoclonal Antibody in Patients With Liver Metastases From Colorectal Cancer With ctDNA Superselective Negative Genes

33 enrolled

Liver Metastases of Colorectal Cancer

NCT06480630 2024-06-28

Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal Antibody-Containing GVHD Prophylaxis Scheme to Reduce the Incidence of Severe Acute GVHD After Umbilical Cord Blood Transplantation for Malignant Hematologic Diseases

Other hematologic neoplasm

39 enrolled

Hematologic Neoplasms

NCT06475443 2024-06-26

Efficacy of Pyrotinib Plus Capecitabine in HER2-positive MBC With Active Brain Metastases That Have Failed ADCs

32 enrolled

Metastatic Breast Cancer in the Brain

NCT06468644 2024-06-21

Phase II Study of Different Doses of Radiotherapy Combined With Sintilimab in the Treatment of Locally Advanced Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

NCT06468670 2024-06-21

Short-course Radiotherapy Combined With Sintilimab for Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma

30 enrolled

Esophageal Squamous Cell Carcinoma

NCT06441045 2024-06-04

Double Dose of Third-generation EGFR-TKI Plus Intrathecal Pemetrexed Versus Double Dose of Third-generation EGFR-TKI in Patients With LM Progression Following the Treatment of Routine Dose of Third-generation EGFR-TKI

112 enrolled

CNS

Meningeal Carcinomatosis

NCT06427213 2024-05-23

This is a Phase II, Open-label, Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma

41 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT06331845 2024-03-26

Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma

39 enrolled

Nasopharyngeal Carcinoma

NCT06233877 2024-02-28

GFLIPM